DC
ARRY

Deere & Company’s Array Biopharma Inc ARRY Stock Holding History

Deere & Company’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,792
Closed -$190K – 1151
2015
Q1 		$190K Buy
+25,792
New +$184K 0.01% 913
2014
Q2 		– Sell
-31,735
Closed -$149K – 1060
2014
Q1 		$149K Hold
31,735
– – 0.01% 891
2013
Q4 		$159K Hold
31,735
– – 0.01% 956
2013
Q3 		$197K Buy
+31,735
New +$189K 0.01% 915

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deere & Company's ARRY Position: Q2 2015 in Review

Deere & Company sold out of Array Biopharma Inc (ARRY) in Q2 2015, closing a stake of 25,792 shares — an estimated $190K sold.

Deere & Company first reported a position in ARRY in Q3 2013 and held it in 4 quarters. The position peaked at $197K in Q3 2013. 148 funds tracked by Wall St. Rank hold ARRY as of Q2 2015.

  • Deere & Company reported no remaining Array Biopharma Inc position as of Q2 2015 after selling out during the quarter.
  • Deere & Company sold 25,792 Array Biopharma Inc shares in Q2 2015, an estimated $190K.
  • Deere & Company first reported a position in Array Biopharma Inc in Q3 2013 and held it in 4 quarters.
  • Deere & Company's Array Biopharma Inc position peaked at $197K in Q3 2013.
  • 148 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2015.

Based on Deere & Company's 13F filing for Q2 2015, filed 13 Aug 2015.